Aventis awards ClinPhone preferred supplier status
October 29, 2003Research and Development
Aventis has made ClinPhone its preferred provider for data management of it clinical trials worldwide.Specialists in telephone and internet-based electronic …
Do doctors really use the Internet?
October 29, 2003Sales and Marketing doctors, internet
Ever since the medical and pharmaceutical web emerged in the mid-90s, technology advocates have assumed that widespread use of the …
Zyprexa approved for bipolar disorder
October 29, 2003Sales and Marketing
Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.The approval makes …
New HRT study shows doubling of cancer risk
October 29, 2003Research and Development
A new study of over one million UK women has confirmed an increased risk of breast cancer from all forms …
Retaining the talent you recruit
October 29, 2003Business Services recruitment, strategy
The vast majority of people who want to work in the pharma industry have high ideals and wish to be …
Merck expands into US proteomics
October 29, 2003Research and Development
Merck KGaA has bought ProtoPlex, a US-based biotech company specialising in functional genomics and proteomics.Privately owned Protoplex will be integrated …
Shire cuts back ahead of US expansion
October 29, 2003Sales and Marketing
Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical …
Genzyme buys SangStat for $600m
October 29, 2003Research and Development
US biotech company Genzyme is to buy SangStat, a California-based company whose lead product Thymoglobulin is a $77 million-a-year treatment …
Pfizer/Pharmacia mega-merger gains final clearance
October 29, 2003Sales and Marketing
The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance …
AstraZeneca prepares Crestor for battle
October 29, 2003Sales and Marketing
AstraZeneca's US salesforce is gearing up to launch its potential blockbuster cholesterol-reducing drug Crestor, after receiving a long-awaited FDA approval.Crestor …
Yamanouchi reinforces US future with GSK deal
October 29, 2003Sales and Marketing
Japanese pharma company Yamanouchi has struck a deal to co-market its forthcoming overactive bladder treatment with GlaxoSmithKline in the US. …
Exanta on NICE list ahead of marketing authorisation
October 29, 2003Sales and Marketing
AstraZeneca's Exanta is to be in NICE's next programme of appraisals even though the blood-thinning drug has not yet received …
Pharma upbeat on the future of online detailing
October 29, 2003Medical Communications e-detailing, survey
The UK pharma industry remains open-minded about using online detailing, but wants to see more evidence of its effectiveness, a …
Aventis sues generic rivals over Lovenox
October 29, 2003Sales and Marketing
Aventis has gone to court in the US to prevent generic versions of its second-biggest drug, blockbuster anti-thrombotic treatment Lovenox, …
BMJ puts industry relations under spotlight
October 29, 2003Sales and Marketing
Patients would benefit from less involvement between pharmaceutical companies and the medical profession, according to new research.A study of more …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
